Covalon wins CE Mark for Biostep collagen dressings

The CE Marking ensures the free movement of Biostep within the European Free Trade Association (with the exception of Switzerland) and EU single market (total 28 countries).

Biostep and BiostepAg are manufactured in the US by Covalon Technologies, exclusively for Smith & Nephew.

Frank DiCosmo, CEO and president of Covalon, said: “We are very pleased that the company has received CE Marking for Biostep collagen wound dressings in the EU. The CE Marking enhances the confidence in our advanced collagen wound dressings, improves our product portfolio and marketability. In addition, the CE Marking allows our partner, Smith & Nephew, access to the EU marketplace.”